Page 3 - Claudia Ulbrich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cardior Pharmaceuticals: Cardior Welcomes Dr Orly Vardeny as Permanent Guest to the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins

United statesRussell greigClaudia ulbrichKostenloser wertpapierhandelEva mulderClaudia ulbrich evaUniversity of minnesota medical schoolUniversity of minnesotaCardior pharmaceuticals gmbTrophic communicationsCardior pharmaceuticalsOrly vardenyMinnesota medical schoolAssociate editorHeart failureAmerican college

Cardior Appoints Axel-Sven Malkomes as Chief Financial Officer

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes

Kellogg schoolUnited statesHong kongUnited kingdomRussell greigClaudia ulbrichDonaldson lufkin jenretteKostenloser wertpapierhandelEva mulderAxel sven malkomesClaudia ulbrich evaUniversity of science technology in hong kongCredit suisseTrophic communicationsDeutsche bankLehman brothers

Cardior Pharmaceuticals: Cardior Appoints Dr Russell Greig as Independent Chairman of the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr. Russell Greig

United kingdomRussell greigClaudia ulbrichKostenloser wertpapierhandelClaudia ulbrich barbara gaertner rupprechtMarkus hosangRussellg greigCharlotte spitzCardior pharmaceuticals gmbUniversity of manchesterTrophic communicationsCardior pharmaceuticalsGlaxosmithkline pharmaceuticals internationalGeneral partnerManaging directorVice chairman

Cardior Pharmaceuticals GmbH: Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Cardior Pharmaceuticals GmbH: Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandUnited statesClaudia ulbrichKostenloser wertpapierhandelClaudia ulbrich barbara gaertner rupprechtKarin kleinhansSimone bottiCharlotte spitzDementia fundLoncode instituteCardior pharmaceuticals gmbBristol myers squibbCompany advisory boardTrophic communicationsCardior pharmaceuticalsInkef capital

Cardior Raises €64M in Series B Funding

Cardior Raises €64M in Series B Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Claudia ulbrichBristol myers squibbCompany advisory boardCardior pharmaceuticalsInkef capitalHadean venturesChief executive officer